Drug Shortage Report for TARO-SUNITINIB
Report ID | 238726 |
Drug Identification Number | 02524058 |
Brand name | TARO-SUNITINIB |
Common or Proper name | Sunitinib |
Company Name | TARO PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | SUNITINIB |
Strength(s) | 12.5MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 3x10 Blisters |
ATC code | L01EX |
ATC description | |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2024-09-25 |
Estimated end date | 2024-11-15 |
Actual end date | 2024-11-08 |
Shortage status | Resolved |
Updated date | 2024-12-02 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 130 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2024-12-02 | French | Compare |
v7 | 2024-12-02 | English | Compare |
v6 | 2024-11-11 | French | Compare |
v5 | 2024-11-11 | English | Compare |
v4 | 2024-10-17 | French | Compare |
v3 | 2024-10-17 | English | Compare |
v2 | 2024-09-27 | French | Compare |
v1 | 2024-09-27 | English | Compare |
Showing 1 to 8 of 8